GoTo Telemed Launches Comprehensive Dyslipidemia Management Program
eTravel Wire/10348229

KALISPELL, Mont. - eTravelWire -- GoTo Telemed, the nation's leading integrated telehealth ecosystem serving over 10 million patients nationwide, today announced the launch of its dedicated Dyslipidemia Management Program, a comprehensive virtual care service designed to achieve and sustain aggressive guideline‑directed lipid targets through remote pharmacist‑led medication management, structured telehealth follow‑up, and integrated cardiovascular risk monitoring.

Dyslipidemia is a leading risk factor for atherosclerotic cardiovascular disease (ASCVD), the most common cause of preventable death in the industrialised world. Current AHA/ACC guidelines recommend high‑intensity statin (HIS) therapy with stepwise addition of ezetimibe, PCSK9 inhibitors and other lipid‑lowering agents (LLTs) to achieve LDL‑C <55 mg/dL for very high‑risk patients and <70 mg/dL for high‑risk patients. Yet real‑world achievement of these targets remains suboptimal, especially in underserved populations, due to barriers in follow‑up, medication adherence and access to advanced LLTs. GoTo Telemed's program directly overcomes these obstacles by embedding a Pharm.D.‑led virtual clinic and remote biomarker monitoring within a unified telehealth platform.

More on eTravel Wire

• Corporate Teams Abandon Conference Rooms for Immersive Estates Near Washington DC
• AutoProIT Achieves Cyber Essentials Certification, Reinforcing Its Commitment to Secure Digital Transformation
• DayPass llega a ChatGPT y Claude
• DayPass launches in ChatGPT and Claude
• Renkeer Water Quality Sensors Support Efficient Operation of AI Liquid Cooling Systems

"Lipid management is a cornerstone of cardiovascular prevention, yet countless patients remain at risk because they fail to achieve the aggressive LDL‑C targets that modern therapy can deliver," said a GoTo Telemed spokesperson. "Our Dyslipidemia Management Program closes the evidence–practice gap through a scalable, virtual, pharmacist‑driven model. Patients receive structured remote follow‑up, algorithmic medication titration, and continuous performance monitoring—all without the need for repeated in‑person visits."
The program leverages algorithm‑guided remote monitoring technology that has demonstrated improved health equity in both hypertension and cholesterol management. Pharmacists, guided by electronic medical record (EMR) tools and evidence‑based protocols, initiate and titrate medications to guideline‑directed targets. Using digitally connected home blood pressure monitors and laboratory‑coordinated lipid panels, the platform transmits physiologic and lipid data directly to the patient's electronic health record, enabling real‑time, data‑driven treatment adjustments.

More on eTravel Wire

• Victor Archibong Expands ItsArchiDuh Creator Brand
• ClearSight Therapeutics Receives U.S. Patent Notice of Allowance
• Revinate launches hospitality's first data activation platform
• HLN Consulting Names Lilly Kan as Its First Chief Executive Officer
• BitTitan Accelerates Large-Scale Document Migrations with MigrationWiz

In a large health‑system study of over 10,000 patients, this remote, algorithm‑driven approach achieved a 50% reduction in LDL‑C (from 140 mg/dL to 70 mg/dL) in those who reached a guideline‑recommended lipid‑lowering regimen. Telehealth is increasingly recognised as a crucial tool to improve lipid management, especially for patients in rural or medically underserved areas.

Media Contact:
GoTo Telemed Media Relations
info@gototelemed.com
(660) 628-1660
https://gototelemed.com/